Literature DB >> 23473812

Potential molecular mechanisms for decreased synaptic glutamate release in dysbindin-1 mutant mice.

Shalini Saggu1, Tyrone D Cannon, J David Jentsch, Antonieta Lavin.   

Abstract

Behavioral genetic studies of humans have associated variation in the DTNBP1 gene with schizophrenia and its cognitive deficit phenotypes. The protein encoded by DTNBP1, dysbindin-1, is expressed in forebrain neurons where it interacts with proteins mediating vesicular trafficking and exocytosis. It has been shown that loss of dysbindin-1 results in a decrease in glutamate release in the prefrontal cortex; however the mechanisms underlying this decrease are not fully understood. In order to investigate this question, we evaluated dysbindin-1 null mutant mice, using electrophysiological recordings of prefrontal cortical neurons, imaging studies of vesicles, calcium dynamics and Western blot measures of synaptic proteins and Ca(2+) channels. Dysbindin-1 null mice showed a decrease in the ready releasable pool of synaptic vesicles, decreases in quantal size, decreases in the probability of release and deficits in the rate of endo- and exocytosis compared with wild-type controls. Moreover, the dysbindin-1 null mice show decreases in the [Ca(2+)]i,expression of L- and N-type Ca(2+)channels and several proteins involved in synaptic vesicle trafficking and priming. Our results provide new insights into the mechanisms of action of dysbindin-1.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23473812      PMCID: PMC3628687          DOI: 10.1016/j.schres.2013.01.037

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  51 in total

1.  Synapsin dispersion and reclustering during synaptic activity.

Authors:  P Chi; P Greengard; T A Ryan
Journal:  Nat Neurosci       Date:  2001-12       Impact factor: 24.884

Review 2.  Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene.

Authors:  Ariana P Mullin; Avanti Gokhale; Jennifer Larimore; Victor Faundez
Journal:  Mol Neurobiol       Date:  2011-04-26       Impact factor: 5.590

3.  The synaptic hypothesis of schizophrenia.

Authors:  W Gordon Frankle; Juan Lerma; Marc Laruelle
Journal:  Neuron       Date:  2003-07-17       Impact factor: 17.173

4.  Optimizing synaptic architecture and efficiency for high-frequency transmission.

Authors:  Holger Taschenberger; Ricardo M Leão; Kevin C Rowland; George A Spirou; Henrique von Gersdorff
Journal:  Neuron       Date:  2002-12-19       Impact factor: 17.173

5.  Synaptic vesicle mobilization is regulated by distinct synapsin I phosphorylation pathways at different frequencies.

Authors:  Ping Chi; Paul Greengard; Timothy A Ryan
Journal:  Neuron       Date:  2003-04-10       Impact factor: 17.173

6.  Identification of a syntaxin-binding site on N-type calcium channels.

Authors:  Z H Sheng; J Rettig; M Takahashi; W A Catterall
Journal:  Neuron       Date:  1994-12       Impact factor: 17.173

7.  Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia.

Authors:  M P Vawter; L Thatcher; N Usen; T M Hyde; J E Kleinman; W J Freed
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

8.  Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1).

Authors:  Wei Li; Qing Zhang; Naoki Oiso; Edward K Novak; Rashi Gautam; Edward P O'Brien; Caroline L Tinsley; Derek J Blake; Richard A Spritz; Neal G Copeland; Nancy A Jenkins; Dominick Amato; Bruce A Roe; Marta Starcevic; Esteban C Dell'Angelica; Rosemary W Elliott; Vishnu Mishra; Stephen F Kingsmore; Richard E Paylor; Richard T Swank
Journal:  Nat Genet       Date:  2003-08-17       Impact factor: 38.330

9.  Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.

Authors:  M Ayalew; H Le-Niculescu; D F Levey; N Jain; B Changala; S D Patel; E Winiger; A Breier; A Shekhar; R Amdur; D Koller; J I Nurnberger; A Corvin; M Geyer; M T Tsuang; D Salomon; N J Schork; A H Fanous; M C O'Donovan; A B Niculescu
Journal:  Mol Psychiatry       Date:  2012-05-15       Impact factor: 15.992

10.  The schizophrenia susceptibility factor dysbindin and its associated complex sort cargoes from cell bodies to the synapse.

Authors:  Jennifer Larimore; Karine Tornieri; Pearl V Ryder; Avanti Gokhale; Stephanie A Zlatic; Branch Craige; Joshua D Lee; Konrad Talbot; Jean-Francois Pare; Yoland Smith; Victor Faundez
Journal:  Mol Biol Cell       Date:  2011-10-12       Impact factor: 4.138

View more
  15 in total

1.  Effects of fingolimod administration in a genetic model of cognitive deficits.

Authors:  D Becker-Krail; A Q Farrand; H A Boger; A Lavin
Journal:  J Neurosci Res       Date:  2016-07-20       Impact factor: 4.164

2.  The Proteome of BLOC-1 Genetic Defects Identifies the Arp2/3 Actin Polymerization Complex to Function Downstream of the Schizophrenia Susceptibility Factor Dysbindin at the Synapse.

Authors:  Avanti Gokhale; Cortnie Hartwig; Amanda H Freeman; Ravi Das; Stephanie A Zlatic; Rachel Vistein; Amelia Burch; Guillemette Carrot; Arielle F Lewis; Sheldon Nelms; Dion K Dickman; Manojkumar A Puthenveedu; Daniel N Cox; Victor Faundez
Journal:  J Neurosci       Date:  2016-12-07       Impact factor: 6.167

3.  Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophrenia.

Authors:  Anita L Pinner; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2014-02-22       Impact factor: 4.939

4.  Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning.

Authors:  W Bailey Glen; Bryant Horowitz; Gregory C Carlson; Tyrone D Cannon; Konrad Talbot; J David Jentsch; Antonieta Lavin
Journal:  Hippocampus       Date:  2013-11-12       Impact factor: 3.899

5.  Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes.

Authors:  Jennifer Larimore; Stephanie A Zlatic; Avanti Gokhale; Karine Tornieri; Kaela S Singleton; Ariana P Mullin; Junxia Tang; Konrad Talbot; Victor Faundez
Journal:  J Biol Chem       Date:  2014-04-08       Impact factor: 5.157

6.  Dysbindin-1 contributes to prefrontal cortical dendritic arbor pathology in schizophrenia.

Authors:  Glenn T Konopaske; Darrick T Balu; Kendall T Presti; Grace Chan; Francine M Benes; Joseph T Coyle
Journal:  Schizophr Res       Date:  2018-05-11       Impact factor: 4.939

7.  BDNF rescues prefrontal dysfunction elicited by pyramidal neuron-specific DTNBP1 deletion in vivo.

Authors:  Wen Zhang; Kathryn M Daly; Bo Liang; Lifeng Zhang; Xuan Li; Yun Li; Da-Ting Lin
Journal:  J Mol Cell Biol       Date:  2017-04-01       Impact factor: 6.216

8.  Impairments in brain-derived neurotrophic factor-induced glutamate release in cultured cortical neurons derived from rats with intrauterine growth retardation: possible involvement of suppression of TrkB/phospholipase C-γ activation.

Authors:  Tadahiro Numakawa; Tomoya Matsumoto; Yoshiko Ooshima; Shuichi Chiba; Miyako Furuta; Aiko Izumi; Midori Ninomiya-Baba; Haruki Odaka; Kazuo Hashido; Naoki Adachi; Hiroshi Kunugi
Journal:  Neurochem Res       Date:  2014-03-06       Impact factor: 3.996

Review 9.  Neurodevelopmental disease mechanisms, primary cilia, and endosomes converge on the BLOC-1 and BORC complexes.

Authors:  Cortnie Hartwig; William J Monis; Xun Chen; Dion K Dickman; Gregory J Pazour; Victor Faundez
Journal:  Dev Neurobiol       Date:  2017-10-13       Impact factor: 3.964

10.  Loss of dysbindin-1 affects GABAergic transmission in the PFC.

Authors:  H Trantham-Davidson; A Lavin
Journal:  Psychopharmacology (Berl)       Date:  2019-06-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.